Tag: Correvio
AHA 2019: Correvio announces new data from SPECTRUM Brinavess study
Correvio announced the presentation of new data from the SPECTRUM study evaluating Brinavess (vernakalant hydrochloride, IV), an antiarrhythmic drug for the rapid conversion of...